SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NanoViricides, Inc. Reports Its Oral FluCide® Anti-Influenza Drug Candidates Are Superior to Oral Oseltamivir (TamiFlu®) in H1N1 Influenza Lethal Infection Model